Learn
A complete library of Solu genomic epidemiology content for confidence in every outbreak.
.png)
Featured article
Introducing cgMLST: a second way to compare your samples
Solu now offers cgMLST, a second way to compare your samples. Built on community-standard schemes and validated against published studies, it makes results comparable across institutions.
Latest posts


Research
Explore the Most Comprehensive Set of Acinetobacter baumannii Genomes on Solu
You can now view the most comprehensive dataset of 100 diverse Acinetobacter baumannii genomes directly on Solu!


Research
Genomic investigation of a Shiga toxin-producing Escherichia coli O26:H11 outbreak
Follow a genomic investigation into a Shiga toxin producing E.coli outbreak


Research
Analyzing Candida genomes with candida.app & Solu
The emerging fungal pathogen Candida auris is a growing public health threat due to its fast spread, multidrug-resistance, high transmissibility, and high mortality rates. We created a free web application called candida.app for fast and easy genomic characterization of C.auris isolates.


Research
Investigating a Salmonella Typhi outbreak with Solu Platform
Salmonella Typhi is a bacterial pathogen that causes typhoid fever, a serious illness affecting millions of people worldwide. In this case study, we will explore the use of the Solu platform to investigate a Salmonella Typhi outbreak and analyze the genomic data associated with it.


Research
Validating the results of candida.app and Solu Platform
Candida auris is an emerging health threat, and better genomic analysis tool are needed for its surveillance. Candida.app is a free, user-friendly tool for genomic analysis of C. auris isolates. This validation study shows that Solu and candida.app are accurate for genomıc characterization of Candida auris.
In the press
Nordic Life Science
Sam Sihvonen: Preventing the next pandemic
BioPharma-Reporter
Solu launches ‘fastest’ online tool to prevent Candida auris outbreaks
DigitalHealth
Digital Health Coffee Time Briefing ☕
Genetic Engineering & Biotechnology News
Antimicrobial Resistance Multiple Threats, Multiple Responses
Pharmaceutical Manufacturer
%201.png)


.avif)









